Cargando…

Identifying specific needs in adult cystic fibrosis patients: a pilot study using a custom questionnaire

BACKGROUND: Adult patients with cystic fibrosis (CF) experience daily physical symptoms and disabilities that can be challenging to address for health care teams. METHODS: We sought to identify the most frequent topics that CF adults need to discuss with health care teams using a custom questionnair...

Descripción completa

Detalles Bibliográficos
Autores principales: Dury, Sandra, Perotin, Jeanne-Marie, Ravoninjatovo, Bruno, Llerena, Catherine, Ancel, Julien, Mulette, Pauline, Griffon, Muriel, Carré, Sophie, Perrin, Amélie, Lebargy, François, Deslée, Gaëtan, Launois, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371823/
https://www.ncbi.nlm.nih.gov/pubmed/34404378
http://dx.doi.org/10.1186/s12890-021-01613-4
Descripción
Sumario:BACKGROUND: Adult patients with cystic fibrosis (CF) experience daily physical symptoms and disabilities that can be challenging to address for health care teams. METHODS: We sought to identify the most frequent topics that CF adults need to discuss with health care teams using a custom questionnaire including 62 items. RESULTS: Fifty patients were included, 70% men, mean age 27.6 years, with a mean body mass index of 21.8 kg/m(2). Mean FEV(1)% was 64% of predicted value. Forty-two percent of patients selected at least one topic. The most frequently selected topics were fatigue (20%), professional or scholar worries (18%), procreation (16%), physical activities (16%) and evolution of CF disease (16%). Women were more frequently concerned about fatigue, procreation and profession/school. CONCLUSIONS: Using a custom questionnaire, we identified that CF adults express various unmet needs that extend beyond usual respiratory and nutritional concerns or treatment adherence. The interest of this questionnaire by health care team for improving therapeutic management of CF patients remains to be validated. Trial registration: The study was registered on ClinicalTrials.gov (NCT02924818) on 5th October 2016.